SpyGlass Pharma, Inc.

SGP

Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
SEC CIK: 0001778922

SEC filings (opens in a new tab)

No open-market purchases or sales by SpyGlass Pharma, Inc. insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $581.1M in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding SpyGlass Pharma, Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026 All holders in Q4 2025

13F holders of SGP: Q4 2025 compared with Q1 2026
Measure	Q4 2025	Q1 2026	Change
Holders	0	35	+35
Shares	0	25.4M	+25.4M
Value	$0	$655.4M	+$655.4M

New holders (35)

Institutions that held SpyGlass Pharma, Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to SGP in Q1 2026
Institution	Shares	Value	% of portfolio
Ra Capital Management, L.P.	8,021,117	$207.8M	2.20%
NEA Management Company, LLC	7,392,301	$191.5M	10.89%
Sands Capital Ventures, LLC	2,500,012	$64.8M	15.38%
Samsara BioCapital, LLC	2,109,953	$54.7M	5.31%
Price T Rowe Associates Inc	704,440	$18.3M	0.00%
Vestal Point Capital, LP	666,760	$17.3M	0.48%
Deerfield Management Company, L.P. (Series C)	550,000	$14.3M	0.17%
JPMorgan Chase & Co	577,109	$13.5M	0.00%
Millennium Management LLC	468,794	$12.1M	0.01%
Vanguard Capital Management LLC	434,813	$11.3M	0.00%
First Light Asset Management, LLC	375,000	$9.72M	0.87%
Franklin Resources Inc	300,000	$7.77M	0.00%
Affinity Asset Advisors, LLC	250,000	$6.48M	0.38%
Standard Life Aberdeen plc	220,454	$5.71M	0.01%
BlackRock, Inc.	144,739	$3.75M	0.00%
Geode Capital Management, LLC	126,540	$3.28M	0.00%
Monashee Investment Management LLC	95,000	$2.46M	1.34%
Vanguard Fiduciary Trust Co	59,782	$1.55M	0.00%
Charles Schwab Investment Management Inc	59,610	$1.54M	0.00%
Alyeska Investment Group, L.P.	57,000	$1.48M	0.00%
TD Asset Management Inc	47,580	$1.23M	0.00%
Ameriprise Financial Inc	44,477	$1.15M	0.00%
Marshall Wace, LLP	29,348	$760.4K	0.00%
Bank of America Corp	28,020	$726.0K	0.00%
Northern Trust Corp	20,862	$540.5K	0.00%
Goldman Sachs Group Inc	19,283	$499.6K	0.00%
State Street Corp	17,250	$446.9K	0.00%
Manufacturers Life Insurance Company, The	11,870	$307.6K	0.00%
Squarepoint Ops LLC	7,811	$202.4K	0.00%
Vanguard Global Advisers, LLC	4,927	$127.7K	0.00%
Morgan Stanley	4,179	$108.3K	0.00%
Vanguard Portfolio Management LLC	3,680	$95.3K	0.00%
UBS Group AG	455	$11.8K	0.00%
Barclays PLC	140	$3.63K	0.00%
Royal Bank of Canada	85	$2.00K	0.00%

Sold out (0)

Institutions that held SpyGlass Pharma, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

None.